Delivery Order SPE2DB22D3401-SPE2DB24FT2SF
Award Date 4/17/24
Potential Completion Date 4/18/24
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 2% Viscous 15 ML Cup UD 15ML, a pharmaceutical product. The contract has a firm fixed price and a ceiling value of $1,684.84. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,611.60, is for the delivery of 4567117520 - Lidocaine 2% Viscous 15 ML Cup UD 15ML, a pharmaceutical product, to support military healthcare programs. The order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $1,003.58, is for the procurement of 4565927881 - Lidocaine 2% Viscous 15 ML Cup UD 15ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $1,184.71 firm fixed price delivery order is for the provision of 4564377376 - Lidocaine 2% Viscous 15 ML CUP UD 15ML, with an ultimate completion date of April 24, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at up to...
- This federal contract award, identified as SPE2DB22D2005|SPE2DB25FJEC5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $2,269.72, is for the delivery of Lidocaine 2% Viscous 15 ML CUP UD 15ML, a medical product used in various healthcare settings. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award, valued at $4,256.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4564450876 - Lidocaine 2% Viscous 15 ML Cup UD 15ML, with a completion date of May 1, 2024. This is a Firm Fixed Price, Delivery Order contract type. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds significant Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 100ml bottles of 2% lidocaine viscous solution, with a potential value of $1,335.63 and a completion date of March 4, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is issued under a larger indefinite...
- This delivery order, awarded September 15, 2025, provides Lidocaine 2% Viscous in 15 mL unit dose cups to the Defense Logistics Agency (DLA) with a ceiling value of $1,667.77 and firm fixed pricing. The contract is not set-aside and was competitively awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. Performance will be completed by September 16, 2025, reflecting the expedited nature of this medical supply delivery order....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,509.92, is for the delivery of 4567376999 - Lidocaine HCL 4% Solution 4ML. This is a firm-fixed-price contract with a completion date of February 26, 2025. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lidocaine 2% Viscous Solution in 100ml bottles. The contract has a ceiling value of $9,165.50 and a completion date of November 16, 2023. This is not a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB24FT2SFDelivery Order
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of 4,564,313,846 units of Lidocaine 2% Viscous 15 ML Cup. The contract has a firm-fixed price of $1,175.73 and a completion date of April 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract does not have a set-aside designation.
Generated 7/17/24, 9:57 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 4/17/24 |